Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-331933      Publish Date : Tuesday, November 12, 2013 Visit : 19052

Intl. Congress form | International Congress Report | International Congress Report For Faculty | The Sixteenth Congress of the International Pediatric Nephrology Association

The Sixteenth Congress of the International Pediatric Nephrology Association
The Report of The Sixteenth Congress of the International Pediatric Nephrology Association by Dr.Nakysa Hooman
Application Code :
306-0213-0013
 
Created Date : Sunday, September 15, 2013Update Date : Sunday, November 10, 2013IP Address :2.146.235.141
Submit Date : Sunday, November 10, 2013Email : nhooman@tums.ac.ir
Personal Information
Name : Nakysa
Surname : Hooman
School/Research center : Medical University
Possition : Associate professor
Tel : +98-21-88002904
E-mail : nhooman@tums.ac.ir
Information of Congress
Title of the Congress : The Sixteenth Congress of the International Pediatric Nephrology Association
Title of your Abstract : Cystatin C as an Early Marker of Diabetic Nephropathy in
Children with Type 1 Diabetes Mellitus
Venue : Shanghai International Convention Center
From : Friday, August 30, 2013
To : Tuesday, September 03, 2013
Abstract(Please copy/paste the abstract send to the congress) : Objective: Microalbuminuria is a sensitive marker to detect early
nephropathy in diabetes mellitus.Hypothesis: Cystatin C has a better
correlation than serum creatinine with microalbuminuria in type 1
diabetes mellitus (T1D).Subjects: A hundred patients with stable T1D
and 66 sex-matched healthy children.
Methods: Fasting blood sample was drawn for HbA1C, creatinine, and
cystatin-C and a 24 hour urine aliquot was collected to measure
microalbumin, creatinine, and volume to estimate glomerular filtration
rate (eGFR) based creatinine, cystatin-C, and creatinine+cystatin-C.
Binary logistic regression analysis, Chi-square, ANOVA, and Student's
T test were used to analyze data. P<0.05 was considered significant.
Results: Median serum creatinine and serum cystatin-C were different in
patients and controls (P<0.05). eGFRs based cystatin-C in overall were
higher than eGFRs based creatinine, or eGFR based creatinine+cystatin-
C. About 37.5% children with T1D had microalbuminuria that was
associated with GFR bases cystatin-C less than 60 and more than 130
ml/min/1.73m2 (P<0.05). GFR based creatinine was lower compared to
eGFR based cyatatin-C in T1D regardless of microalbuminuria (P< 0.05).
The frequency of chronic kidney disease classification based on eGFR
basedcreatinine and eGFRbasedcystatin-C were statistically different between
controls and patients. GFR based cystatin-C seemed to
overestimate and eGFR based creatinine underestimate.
Conclusion: There was higher correlation between abnormal eGFR
based cystatin-C and microalbuminuria in diabetic children. eGFR
based creatinine could detect higher rate of GFR less than
60ml/min/1.73m2.
Keywords of your Abstract : Cystatin C, Diabetes Mellitus type 1, e GFR
Acceptance Letter :
The presentation : Poster
The Cover of Abstract book :
Published abstract in the abstract book with the related code :
Where has your abstract been indexed? : ISI
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : more than 1500
Delegates from which countries presented in the congress? : more than 110- form Turkey, UK, Spain, Italy, china, Malaysia, USA, Germany,Libya, Egypt, Korea, India, Iran, etc
Were the delegates of any other organizations present in the congress? : Yes
If yes, please write the names of the organizations in the box : IPNA
What were the responses to your talking points? Were specific questions or concerns raised? : the discrepancy between different formula used for measurement of GFR and the need to use a gold standard for validification.
The new concept of renal osteodystrophy treament.
If you met staff members, please list their full names & positions. : Salusky- president of congress
Martin Taylor- Full professssor, nominated in HUS investigation
allen watson-Full professorm nominated in transition from child to adult
Please inform us if there are any follow up actions we need to talk with the members of the congress : It would be a good idea to find a way to be registered as a member, to be able to participatie in global registeries and trials, to present our center as sister center for training program that is now available in singapour and india. I think our center can compete as a good source of training. nw modalities of treatment for some disease such as aHUS is availble now and if it show its long term efficacy, it worth to bu replaced for current ffp and plasmaphresis
Your experiences about the travel processes(Providing ticket, accommodation,...) : the abscence of credit card make early registration, reservation of hotel impossible and if the IPNA executive group did not cooperation, I had no room for accomodation and I had to pay highr price for registration
Please give a briefing of your own observations and outcomes of the congress: : Overall:
Generally speaking, it was a good international congress for updating the old data by attending in various panels, symposium, mini-lectures and oral presentation and reading the posters and the aim of studies and results. 
Challenge:
The presence of enough opportunity and time for discussing about challenging new idea was an excellent experience. In addition, sharing the personal experience of therapy in difficult cases was as goo d as to ask their opinion about their approach in similar condition.
Progress of Nephrology in our country:
One of important point of success was to present the progress of nephrology in Iran, the dark aspect that we try to show it off more. Moreover, to know the head of important departments in other countries and discuss about their facilities with ours was another aspect of congress to negotiate for further holing congress in Iran in attract forging participant in the same field to attend.